Yi-Hao Yen

35PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 21, 2026
Tumor Number and Model for End-Stage Liver Disease Score as Selection Criteria for Resection or Embolization of Intermediate-Stage Hepatocellular Carcinoma.

|Aug 24, 2026
Characteristics and predictors of survival outcomes of patients with large pathology-defined T1b hepatocellular carcinoma undergoing resection.

|Jun 28, 2026
Risk Group Stratification for True Early Recurrence After Ablation for Hepatomas.

|May 13, 2026
Sustained virological response improved survival outcomes after curative resection in patients with hepatitis C virus-related hepatocellular carcinoma in the era of direct‑acting antiviral therapy.

|May 13, 2026
Prognostic Significance of Histologic Steatotic Liver Disease in Curatively Resected Non-B, Non-C Hepatocellular Carcinoma.

|Apr 08, 2026
Predictors of True Early Recurrence in Patients Undergoing Radiofrequency Ablation for Hepatocellular Carcinoma.

Yi-Hao Yen, Kwong-Ming Kee, Chao-Hung Hung

Pageof 6

Frequent Collaborators

6 joint publications

Chao-Hung Hung

5 joint publications

Chien-Hung Chen

5 joint publications

Ming-Chao Tsai

5 joint publications

Yueh-Wei Liu